Does United Healthcare Cover Wegovy? Insurance Guide 2026

Losing weight or managing diabetes with Wegovy can be life-changing, but navigating insurance coverage—especially with United Healthcare—can feel overwhelming. As of 2026, United Healthcare’s policies on Wegovy have evolved, reflecting broader trends in obesity and diabetes care. This guide breaks down everything you need to know about getting Wegovy covered, from eligibility criteria to appeals processes, so you can focus on your health without the financial stress.

---

Does United Healthcare Cover Wegovy for Diabetes?

United Healthcare generally covers Wegovy for patients with type 2 diabetes, but strict criteria apply. As of 2026, Wegovy (semaglutide) is approved by the FDA for chronic weight management and glycemic control in adults with type 2 diabetes, particularly those with obesity or overweight status (BMI ≥27 kg/m² with weight-related comorbidities). United Healthcare aligns its coverage with these FDA guidelines, but only if patients meet specific clinical requirements.

To qualify, patients must demonstrate inadequate glycemic control with metformin or other first-line diabetes medications. United Healthcare typically requires prior authorization, proof of a hemoglobin A1c ≥7.0%, and documentation of failed lifestyle interventions (e.g., diet, exercise). Some plans may also mandate a trial of GLP-1 agonists like Ozempic before approving Wegovy, as both contain semaglutide but are approved for different primary indications.

Coverage may vary by plan tier. For example, employer-sponsored plans often include Wegovy for diabetes under their pharmacy benefits, while Medicare Advantage plans (offered by United Healthcare) may require additional steps, such as a step-therapy protocol. Patients should review their Summary of Benefits or contact United Healthcare directly to confirm their plan’s specifics.

---

Does United Healthcare Cover Wegovy for Weight Loss?

United Healthcare’s coverage of Wegovy for weight loss is more restrictive than for diabetes but has expanded in recent years. As of 2026, Wegovy is covered for adults with a BMI ≥30 kg/m² or a BMI ≥27 kg/m² with at least one weight-related condition (e.g., hypertension, sleep apnea, or dyslipidemia). However, coverage is not guaranteed, and United Healthcare often imposes additional hurdles to limit costs.

Prior authorization is almost always required, and United Healthcare may deny coverage if patients haven’t first tried and failed other weight-loss interventions, such as diet, exercise, or older medications like phentermine. Some plans also require participation in a structured weight-loss program (e.g., Weight Watchers or a physician-supervised plan) for 3–6 months before approving Wegovy.

Coverage also depends on the plan type. For instance, fully insured plans (common in large corporations) are more likely to include Wegovy than self-funded plans, where employers set their own rules. Medicaid plans administered by United Healthcare may have even stricter criteria, often limiting Wegovy to patients with severe obesity (BMI ≥40 kg/m²) or those with obesity-related complications. Patients should verify their plan’s formulary or consult their healthcare provider to navigate these requirements.

---

How Much Does Wegovy Cost With United Healthcare?

The out-of-pocket cost of Wegovy with United Healthcare varies widely depending on the plan’s pharmacy benefits, copay tiers, and deductible status. Without insurance, Wegovy retails for approximately $1,300–$1,600 per month, but United Healthcare negotiates lower rates for its members. For those with coverage, the cost typically falls into one of three categories:

1. Copay or Coinsurance: Most United Healthcare plans classify Wegovy as a Tier 3 or Tier 4 medication, meaning patients pay a copay (e.g., $50–$100 per month) or coinsurance (e.g., 20–30% of the drug’s cost). For example, a plan with 25% coinsurance might leave the patient responsible for $300–$400 per month until their deductible is met.
2. Deductible: If the plan has a high deductible (e.g., $1,500–$3,000), patients may pay the full negotiated price of Wegovy until the deductible is satisfied. After that, copays or coinsurance apply.
3. Prior Authorization or Step Therapy: Some plans require patients to try less expensive alternatives (e.g., generic phentermine) before covering Wegovy, which can delay access and increase overall costs.

Patients can use United Healthcare’s online cost estimator tool or contact customer service to get a personalized estimate. Additionally, Novo Nordisk, the manufacturer of Wegovy, offers a savings card that can reduce out-of-pocket costs to as little as $0–$25 per month for eligible commercially insured patients. However, this program does not apply to Medicare or Medicaid beneficiaries.

---

Wegovy Prior Authorization for United Healthcare

Prior authorization is a standard requirement for Wegovy under most United Healthcare plans, designed to ensure the medication is used appropriately and cost-effectively. The process involves submitting clinical documentation to prove the patient meets United Healthcare’s coverage criteria, which typically include:

• BMI Requirements: For weight loss, a BMI ≥30 kg/m² or ≥27 kg/m² with a weight-related comorbidity. For diabetes, a BMI ≥27 kg/m² with inadequate glycemic control (A1c ≥7.0%).
• Failed Lifestyle Interventions: Documentation of at least 3–6 months of diet, exercise, or behavioral therapy without sufficient weight loss or glycemic improvement.
• Medical History: Evidence of weight-related conditions (e.g., hypertension, sleep apnea) or diabetes complications (e.g., neuropathy, retinopathy).
• Step Therapy: Some plans require patients to try and fail other medications (e.g., phentermine, Orlistat, or Ozempic) before approving Wegovy.

Healthcare providers must submit the prior authorization request through United Healthcare’s online portal or via fax, including lab results, progress notes, and a letter of medical necessity. Approval typically takes 3–10 business days, but denials can occur if documentation is incomplete or criteria aren’t met. Patients can check the status of their request through their United Healthcare member portal or by calling customer service.

If denied, providers can appeal by submitting additional evidence, such as updated lab results or a more detailed explanation of the patient’s clinical need for Wegovy. United Healthcare’s appeals process may take an additional 30–60 days, so patients should start the process as early as possible.

---

How to Get United Healthcare to Cover Wegovy

Securing coverage for Wegovy through United Healthcare requires a strategic approach, combining clinical documentation, persistence, and knowledge of the plan’s rules. Here’s a step-by-step guide to improve your chances:

1. Confirm Eligibility: Verify that you meet United Healthcare’s criteria for Wegovy (e.g., BMI, comorbidities, or diabetes diagnosis). Review your plan’s formulary or Summary of Benefits to confirm Wegovy is listed as a covered medication.
2. Work with Your Provider: Your healthcare provider plays a critical role in the approval process. They must document your medical history, failed weight-loss attempts, and the clinical necessity of Wegovy. Ask them to include specific details, such as:
   • Your current BMI and weight-related conditions.
   • Previous medications or interventions tried (e.g., diet, exercise, other GLP-1 agonists).
   • Lab results (e.g., A1c levels for diabetes patients).
3. Submit Prior Authorization: Your provider must submit a prior authorization request to United Healthcare, including all required documentation. Ensure the request is complete to avoid delays or denials.
4. Appeal If Denied: If United Healthcare denies coverage, your provider can file an appeal. This may involve submitting additional evidence, such as updated lab results or a letter of medical necessity. United Healthcare’s appeals process typically involves:
   • First-Level Appeal: Submitted by your provider within 60 days of the denial.
   • Second-Level Appeal: If the first appeal is denied, your provider can request an external review by an independent third party.
5. Explore Manufacturer Assistance: Novo Nordisk offers a savings card for Wegovy, which can reduce out-of-pocket costs for eligible patients. The card is valid for commercially insured patients and can be combined with United Healthcare coverage to lower costs further.
6. Consider Alternative Coverage: If Wegovy is consistently denied, explore other options, such as switching to a different United Healthcare plan during open enrollment or applying for patient assistance programs through Novo Nordisk.

Persistence is key. Many patients successfully obtain coverage for Wegovy after one or more appeals, especially if their provider advocates strongly on their behalf.

---

What to Do If United Healthcare Denies Wegovy

If United Healthcare denies coverage for Wegovy, don’t give up—there are several steps you can take to challenge the decision and potentially secure approval.

1. Understand the Reason for Denial: United Healthcare must provide a written explanation for the denial. Common reasons include:
   • Incomplete prior authorization documentation.
   • Failure to meet BMI or clinical criteria.
   • Lack of evidence for failed lifestyle interventions or step therapy.
   • Wegovy not being listed on your plan’s formulary.
2. Request a Peer-to-Peer Review: Your provider can request a peer-to-peer review with a United Healthcare medical director. During this call, your provider can present additional clinical evidence and argue for the medical necessity of Wegovy. This step often resolves denials without needing a formal appeal.
3. File an Appeal: If the peer-to-peer review is unsuccessful, your provider can file a formal appeal. This involves submitting a written request with supporting documentation, such as:
   • Updated lab results (e.g., A1c levels, lipid panels).
   • A detailed letter of medical necessity.
   • Evidence of weight-related complications (e.g., sleep study results for sleep apnea). United Healthcare must respond to the appeal within 30–60 days, depending on the plan.
4. Request an External Review: If the internal appeal is denied, you can request an external review by an independent third party. This process is available for all fully insured plans and some self-funded plans. The external reviewer will evaluate the clinical evidence and make a binding decision.
5. Explore Alternative Funding: While appealing, consider alternative ways to access Wegovy:
   • Novo Nordisk’s savings card can reduce out-of-pocket costs for eligible patients.
   • Patient assistance programs may provide Wegovy at no cost for uninsured or low-income patients.
   • Clinical trials or compassionate use programs may offer access to Wegovy for those who qualify.
6. Switch Plans or Insurers: If appeals are exhausted, consider switching to a different United Healthcare plan during open enrollment or exploring other insurers with more favorable coverage for Wegovy.

---

United Healthcare Alternatives If Wegovy Is Not Covered

If United Healthcare denies coverage for Wegovy and appeals are unsuccessful, several alternatives can help you achieve similar health benefits. These options vary in cost, effectiveness, and accessibility, so it’s important to discuss them with your healthcare provider.

1. Other GLP-1 Agonists: United Healthcare may cover alternative GLP-1 agonists, such as:
   • Ozempic (semaglutide): Approved for type 2 diabetes but often prescribed off-label for weight loss. United Healthcare is more likely to cover Ozempic for diabetes, and some patients experience weight loss as a side effect.
   • Saxenda (liraglutide): Approved for weight loss and may be covered under some United Healthcare plans. Saxenda works similarly to Wegovy but requires daily injections.
   • Mounjaro (tirzepatide): A newer GLP-1/GIP agonist approved for diabetes and weight loss. United Healthcare may cover Mounjaro for diabetes, and it has shown superior weight-loss results compared to Wegovy in clinical trials.
2. Non-GLP-1 Weight-Loss Medications: If GLP-1 agonists are not an option, United Healthcare may cover other weight-loss medications, such as:
   • Phentermine: A stimulant that suppresses appetite, often covered for short-term use (3–6 months).
   • Qsymia (phentermine/topiramate): A combination medication that may be covered for long-term weight loss.
   • Contrave (naltrexone/bupropion): An oral medication that may be covered for patients with obesity or overweight with comorbidities.
3. Lifestyle Interventions: United Healthcare often covers structured weight-loss programs, such as:
   • Weight Watchers (WW): Some plans offer discounts or full coverage for WW memberships.
   • Physician-Supervised Programs: Programs like Optifast or medical weight-loss clinics may be covered under certain plans.
   • Nutrition Counseling: Registered dietitians or nutritionists may be covered for patients with obesity or diabetes.
4. Bariatric Surgery: For patients with severe obesity (BMI ≥40 kg/m² or ≥35 kg/m² with comorbidities), United Healthcare may cover bariatric surgery, such as gastric bypass or sleeve gastrectomy. Surgery is typically considered after failed medical interventions.
5. Clinical Trials: Participating in a clinical trial for Wegovy or other weight-loss medications can provide access to the drug at no cost. Websites like ClinicalTrials.gov list ongoing trials for obesity and diabetes treatments.
6. Patient Assistance Programs: Novo Nordisk offers patient assistance programs for **W